ClinicalTrialsFinder

HR+/HER2- Ductal and Lobular Breast Cancer Clinical Trials in Toronto, Ontario

1 recruitingToronto, Ontario, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 1

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Non-small Cell Lung CancerPancreatic Ductal AdenocarcinomaHR+/HER2- Ductal and Lobular Breast Cancer
Novartis Pharmaceuticals162 enrolled31 locationsNCT06562192